When used to treat colonic inflammation induced by TNBS administration to Balb/c mice, ciprofloxacin effectively protected against development of local signs of colitis and markedly reduced local generation of inflammatory mediators including IL-1β, IL-6, IFNγ and TNFα. The gene discussed is IFNG; the disease is inflammatory response.